Note On The Biopharmaceutical Industry

“Note on the Biopharmaceutical Industry” explores the intricacies of the biopharmaceutical landscape, including the evolution from traditional pharmaceuticals to biotech and their convergence. It addresses the challenges of drug development, such as high costs, regulatory hurdles, and intellectual property issues, while highlighting innovations in gene therapy, biologics, and AI-driven solutions. The case provides insights into pricing and market access strategies, ethical concerns, and the industry’s transformative role in improving healthcare outcomes.